http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9612520-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fa2df2d28b9e822c1ae2720d5781fcaf
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-325
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-306
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61N1-40
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-32
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61N1-40
filingDate 1995-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd56c08708662041cedb39710c4d641b
publicationDate 1996-05-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-9612520-A1
titleOfInvention Electroporetic gene and drug therapy by induced electric fields
abstract A method and apparatus are provided for introducing molecules such as genes and pharmaceutical compounds into living blood cells of a patient for therapeutic purposes. A device is placed into contact with the body of the patient for generating an electric field at a preselected location within a selected blood vessel. Preselected molecules are infused into the selected blood vessel. Simultaneously an electric signal is applied to the applied device to repeatedly subject a quantity of blood flowing within the selected blood vessel past the preselected location to electric fields of a predetermined amplitude and duration. The parameters of the electric fields are precisely controlled in order to make the walls of preselected cells in the blood transiently permeable to permit the molecules to enter said preselected cells without killing said cells. The device can include either an induction coil that placed into contact with the body over a blood vessel, or alternatively, an induction coil that surrounds the blood vessel. The electric signal is supplied by a power pack and the preselected molecules are infused with a supply pump.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8058253-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-03038112-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7517863-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8188056-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7361642-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010137021-A2
priorityDate 1994-10-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4970154-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5304120-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394280
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73073
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226411130
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID57417070

Total number of triples: 26.